Four faculty members from the Illinois Grainger College of Engineering have received a total of $475,000 in grants to support ...

UBS analyst Laura Sutcliffe maintained a Buy rating on CSL (CMXHF – Research Report) today and set a price target of A$310.00. The company’s shares closed yesterday at $146.35. Discover ...

CSL (ASX:CSL) has had a rough three months with its share price down 17%. However, stock prices are usually driven by a company’s financials over the long term, which in this case look pretty ...

Jefferies analyst David Stanton maintained a Buy rating on CSL (CMXHF – Research Report) today and set a price target of A$320.00. Discover outperforming stocks and invest smarter with Top Smart ...

Learn More CSL Ltd (ASX: CSL) shares had another poor session on Wednesday. The biotechnology company's shares were down 1.5% to $252.92. This means that they are now down 20% from their 52-week high.

That was after the company descended as low as $229.22 this morning, a new 52-week low for CSL. Thankfully for CSL shareholders, there is a silver lining to this rather woeful Wednesday.

CSL believes, at its current price, Hemgenix can save the US healthcare system $5 million to $5.8 million per person in a lifetime. Naturally, those savings would mean lost revenues to certain ...

In the short term, CSL could be hurt by American tariffs. The US accounts for around half of the company's revenue, and while it collects more than 90% of plasma in the US, it manufactures some of its ...

Carlisle Companies Incorporated operates as a manufacturer and supplier of building envelope products and solutions in the United States, Europe, North America, Asia and the Middle East, Africa ...

Why it matters: Windows 11's Snipping Tool already allows you to copy text from images, offering functionality similar to Apple's Live Text – but Microsoft's implementation involves a few more ...